Chemoinformaics analysis of Chrysoeriol-7-O-Beta-D-Glucoside
| Molecular Weight | 462.407 | nRot | 5 |
| Heavy Atom Molecular Weight | 440.231 | nRig | 24 |
| Exact Molecular Weight | 462.116 | nRing | 4 |
| Solubility: LogS | -3.881 | nHRing | 2 |
| Solubility: LogP | 0.935 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 60.2314 |
| nHD | 6 | BPOL | 29.8826 |
| QED | 0.302 |
| Synth | 3.872 |
| Natural Product Likeliness | 1.867 |
| NR-PPAR-gamma | 0.921 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.96 |
| HIA | 0.856 |
| CACO-2 | -5.976 |
| MDCK | 0.0000388 |
| BBB | 0.154 |
| PPB | 0.802766 |
| VDSS | 0.959 |
| FU | 0.144411 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.109 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.44 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.334 |
| CYP3a4-inh | 0.061 |
| CYP3a4-sub | 0.036 |
| CL | 4.068 |
| T12 | 0.497 |
| hERG | 0.027 |
| Ames | 0.711 |
| ROA | 0.027 |
| SkinSen | 0.098 |
| Carcinogencity | 0.53 |
| EI | 0.013 |
| Respiratory | 0.075 |
| NR-Aromatase | 0.903 |
| Antiviral | Yes |
| Prediction | 0.870304 |